Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

MOMENTUM IN MCDERMOTT’S MIAMI OFFICE CONTINUES WITH ARRIVAL OF SKILLED TRANSACTIONS LAWYER

Roy Larson will Further Enhance Cross-Practice Synergies at the Intersection of Firm’s Health and Corporate Practices

The Miami office of McDermott Will & Emery is pleased to welcome Roy Larson as a partner in the Corporate & Transactional Practice Group.

Mr. Larson represents clients in mergers and acquisitions (M&A) with extensive experience handling domestic and cross-border transactions in the health care sector.  He counsels clients in connection with public and private equity offerings and is known for representing companies in matters involving corporate governance, securities offerings, and joint ventures.

“We are thrilled to welcome Roy to our firm,” said Jerry J. Sokol, Managing Partner of McDermott’s Miami office. “We have known Roy for a long time.  He is an exceptional transactional attorney with a practice focused right on one of our ‘power alleys’ – health care transactions.  By moving his practice to the McDermott platform, where collaboration is paramount, Roy’s practice should really flourish.”

“Roy’s experience at the intersection of health and transactions will further enhance the synergy between two of McDermott’s core practices,” said Harris C. Siskind, global head of McDermott’s Corporate & Transactional Practice Group. “His focus on domestic and cross-border transactions will be a great addition as the collaboration between our corporate and health practices in the US and abroad continues to deliver best-in-class client service across the Firm’s global platform.”

There is a great amount of growth momentum in the Miami office as last month prominent health care litigator, Michael Austin, rejoined McDermott from DLA Piper where he was hiring partner and leader of that firm’s local health care litigation practice.  Experienced litigator, Kamal Sleiman, joined Mr. Austin and together they will focus on advising McDermott clients throughout complex commercial litigation with a particular emphasis on the health care arena.  In order to accommodate recent growth, the Miami office has expanded its physical footprint with the build out of newly acquired space on the 33rd floor of the downtown office tower.  This growth momentum experienced by McDermott’s Miami office reinforces it as one of the Firm’s powerhouse locations with a thriving book of business sustained by a vibrant and energetic culture that fosters creativity and collaboration among lawyers and staff.

Mr. Larson’s arrival not only continues the growth momentum in the Miami office, but it also continues the hiring momentum within McDermott’s Corporate & Transactional Practice Group.  Over the past year the Firm’s US offices have welcomed partners Ivan Presant, Jeffrey Meyers, Armando Ramirez, Josh Samis, Ian Schwartz, Gregory Metz, David Lipkin, Rob Goldstein, Frank Steinherr, Daniel Martin, Jeremy Dickens and Albert Sokol.  In addition to its growth in the US, McDermott’s Corporate & Transactional Practice Group has recently strengthened the depth of its bench around the world with the addition of Peter Crichton, Alan Gar, Elizabeth Moseley, Alicia Videon, Michael Holter, and Piero Carbone in London; Dr. Michael Cziesla and Dr. Oliver Hahnelt in Frankfurt; Alexa Ningelgen and Eva Schöneich in Düsseldorf; and most recently a team in Milan consisting of partners Giancarlo Castorino, Ettore Scandale, and EmidioCacciapuoti.

Mr. Larson received his JD from Columbia and his BS in Economics from the Wharton School at the University of Pennsylvania. He most recently served as the Managing Partner of the Miami Office of Baker & McKenzie, and is also a former member of the Steering Committee for the North America Pharmaceutical and Health Care Industry Group.